OVIVA THERAPEUTICS
Cambrian BioPharma, Inc.
Mark For: OVIVA THERAPEUTICS™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90634639 |
| Mark Literal Elements | OVIVA THERAPEUTICS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2021-12-28 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Matthew D. Delaney |
| Attorney Docket Number | 0742354 |
Timeline
| 2021-04-09 | Application Filed |
| 2021-04-13 | Location: NEW APPLICATION PROCESSING |
| 2021-04-13 | Status: Live/Pending |
| 2021-04-13 | Transaction Date |
| 2021-11-02 | Published |
| 2021-12-28 | Location: INTENT TO USE SECTION |
| 2021-12-28 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
Trademark Parties (Applicants & Owners)
| Party: |  Cambrian BioPharma, Inc. |
| Address | #66643 228 Park Ave. South New York, NEW YORK UNITED STATES 10003 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | 2021-04-09 | |
| TEAS Plus New Application | 2021-04-09 | |
| Examiners Amendment | 2021-09-28 | |
| XSearch Search Summary | 2021-09-28 | |
| Amendment and Mail Process Complete | 2021-09-29 | |
| TRAM Snapshot of App at Pub for Oppostn | 2021-09-29 | |
| Notice of Publication | 2021-10-13 | |
| Notification Of Notice of Publication | 2021-10-13 | |
| OG Publication Confirmation | 2021-11-02 | |
| Notice of Allowance | 2021-12-28 |
Attorney of Record
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the prevention of ovarian disfunction; Pharmaceutical preparations for the prevention of infertility; Pharmaceutical preparations for the prevention of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of ovarian disfunction; Pharmaceutical preparations for the treatment of oncofertoprotection; Pharmaceutical preparations for the treatment of infertility; Pharmaceutical preparations for the treatment of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of reproductive disease; Pharmaceutical preparations for the treatment of neurodegenerative disease; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for evaluating ovarian function; Pharmaceutical preparations for the preservation of ovarian function; Pharmaceutical preparations for the improvement of ovarian function; Pharmaceutical preparations for supporting sex reassignment; Pharmaceutical preparations for contraception; Pharmaceutical preparations for treating indications of reproductive health
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the prevention of ovarian disfunction; Pharmaceutical preparations for the prevention of infertility; Pharmaceutical preparations for the prevention of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of ovarian disfunction; Pharmaceutical preparations for the treatment of oncofertoprotection; Pharmaceutical preparations for the treatment of infertility; Pharmaceutical preparations for the treatment of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of reproductive disease; Pharmaceutical preparations for the treatment of neurodegenerative disease; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for evaluating ovarian function; Pharmaceutical preparations for the preservation of ovarian function; Pharmaceutical preparations for the improvement of ovarian function; Pharmaceutical preparations for supporting sex reassignment; Pharmaceutical preparations for contraception; Pharmaceutical preparations for treating indications of reproductive health |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-12-28 | |
| PUBLISHED FOR OPPOSITION | 2021-11-02 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-11-02 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-10-13 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-09-28 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2021-09-28 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2021-09-28 | 74662 |
| EXAMINER'S AMENDMENT ENTERED | 2021-09-28 | 88888 |
| ASSIGNED TO EXAMINER | 2021-09-28 | 74662 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-09-28 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-07-17 | |
| NEW APPLICATION ENTERED IN TRAM | 2021-04-13 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OVIVA THERAPEUTICS 97603698 not registered Live/Pending |
Cambrian BioPharma, Inc. 2022-09-23 |
 OVIVA THERAPEUTICS 90634639 not registered Live/Pending |
Cambrian BioPharma, Inc. 2021-04-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 